Sat.Feb 18, 2023 - Fri.Feb 24, 2023

article thumbnail

STAT+: How a depression test devised by a Zoloft marketer became a crutch for a failing mental health system

STAT

A bedrock of the U.S. mental health system — a nine-item questionnaire used to spot depression — began not with a doctor, but with a marketing man. Howard Kroplick, now 73 years old and living on Long Island, is obsessed with antique racing cars and, in his storied career in the pharmaceutical industry, crucially urged Pfizer to avoid the word “impotence” when promoting Viagra.

345
345
article thumbnail

Tapping into the molecular fountain of youth

PharmaVoice

Kristen Fortney, CEO of BioAge Labs, wants to improve the human life span by focusing on the human health span.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ACMT Toxicology Visual Pearl: Is the Silver Bullet for Refractory Vasoplegia Really Blue?

ALiEM - Pharm Pearls

What is the proposed mechanism for the pictured antidote when used as a pressor for refractory vasoplegic shock? Alpha-1-adrenergic agonist Angiotensin II receptor antagonist Nitric oxide/cyclic GMP pathway inhibition Vasopressin-1 receptor agonist Reveal the Answer Answer 3 – Inhibition along the nitric oxide (NO)/cyclic GMP pathway Background Vasoplegic shock is a maldistribution of blood flow and inadequate oxygen delivery secondary to an abnormally low systemic vascular resistance [1].

Labelling 173
article thumbnail

CSL’s first gene therapy for haemophilia B approved

Pharma Times

Boost for effected patients as HEMGENIX receives green light from European Commission

156
156
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Opinion: Fixing U.S. public health will require a health-systems revolution — and for physicians to take a backseat

STAT

A classic warning in public health goes like this: “A society that spends so much on health care that it cannot or will not spend adequately on other health enhancing activities may actually be reducing the health of its population.” No nation is as guilty of this practice as the United States, with its extremely high health expenditures alongside abysmal population-level health outcomes.

300
300

More Trending

article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabin

article thumbnail

Sangamo’s ST-920 demonstrates evidence of clinical benefit

Pharma Times

Phase 1/2 research shows that treatment could be very effective against Fabry disease

150
150
article thumbnail

STAT+: Moderna expands CRISPR gene editing research with ElevateBio partnership

STAT

Moderna is aiming to build a gene editing franchise powered by some of the same technologies used in its COVID-19 vaccines. The Cambridge biotech company announced Wednesday that it will partner with Life Edit Therapeutics to develop potentially permanent treatments for rare genetic diseases and other conditions. Life Edit is the North Carolina subsidiary of ElevateBio, a cell and gene therapy manufacturing firm in Waltham.

Vaccines 298
article thumbnail

Biotechs teeter on unsteady ground in 2023 and some may close shop

PharmaVoice

A slew of early stage biotechs were forced to shut down last year as the market tanked. Will the trend continue?

147
147
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

First successful CAR-T treatment for muscle inflammation

European Pharmaceutical Review

University Hospital Erlangen in Germany is the first in the world to use chimeric antigen receptor (CAR) T-cells to successfully treat a patient suffering from a severe case of muscle inflammation (myositis). The researchers noted that risk of developing a very severe form of the autoimmune inflammatory disease is high. The patient who received the CAR T treatment was diagnosed with anti-synthetase syndrome.

article thumbnail

Trio of COVID-19 treatments receive NICE nod

Pharma Times

Final draft guidance from NICE ensures people at highest risk will have access to COVID-19 therapies

150
150
article thumbnail

Opinion: Needed: a new framework to make sure health companies play fair with patient data

STAT

As a health policy wonk and health economist who has worked in pharmaceutical companies in the United States, Latin America, and Europe, I’ve seen vast volumes of data generated, gathered, aggregated, analyzed, shared, and resold by health care companies and organizations. In my studies with the world’s top medical statistics experts at the University of Oxford’s Centre for Evidence Based Medicine, I’ve also seen how flawed many datasets are, missing critical data pie

article thumbnail

Cytokinetics looks to muscle into the cardiovascular market

PharmaVoice

With a scientific platform based on muscle biology, the late-stage biotech is addressing cardiovascular and neuromuscular diseases.

130
130
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

What they are saying: Nonprofit hospitals are gaming the system at the expense of patients

PhRMA

There have been some alarming stories uncovered by the media on ways nonprofit hospitals — many of which participate in the 340B drug pricing program — are taking advantage of the system and their tax-exempt status to boost their bottom lines, at the expense of patients.

Hospitals 122
article thumbnail

Michael J. Fox Foundation funding boost for Newel Health’s Soturi

Pharma Times

Next phase of Newel Health’s digital therapeutics solution for Parkinson’s disease gains vital grant

146
146
article thumbnail

Amid fentanyl crisis, first-of-its-kind study to evaluate expanded methadone access

STAT

Ever since fentanyl entered the U.S. drug supply, many Americans seeking treatment for opioid addiction have found that only a single medication is effective at easing cravings and withdrawal: methadone. But even though the drug is widely considered to be safe and effective, there’s not much data about how methadone stacks up against its main alternative, buprenorphine.

281
281
article thumbnail

Why FDA’s approach to orphan drug exclusivity is ripe for more legal challenges

PharmaVoice

Despite a court ruling, the FDA is sticking to its narrow orphan drug exclusivity approach. But confusion remains over the policy’s future.

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Shining a light on Raman for microbiological analysis

European Pharmaceutical Review

Advances with microbiological methods are providing more accurate and sensitive datasets at a faster rate, relating to bacterial identity, numbers, responses to environments and so on. Recent years have seen progress with applying a long-established spectrophotometric phenomenon – Raman spectra – to advance our understanding of bacterial populations, including differentiating between living and dead cells and interpreting phenotypic variations to different environmental stressors.

Labelling 121
article thumbnail

PBD Biotech broadens patent for tuberculosis diagnostic

Pharma Times

Africa-based trials for blood test which detects risk of disease progression are due to begin

142
142
article thumbnail

Tools to predict stroke risk work less well for Black patients, study finds

STAT

Stroke risk prediction tools are meant to guide how doctors approach a potentially deadly condition, using factors like heart disease and high blood pressure to get a handle on which patients might benefit from a particular treatment. For years, doctors have used several different algorithms to try to capture the true risk of stroke, including newer models that use machine learning.

Hospitals 273
article thumbnail

Why patient care is a public affair

PharmaVoice

The VP of public affairs at Kyowa Kirin discusses her role in advocating for advocacy.

130
130
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Holding pharmacy benefit managers accountable

PhRMA

State legislative sessions across the country are in full swing, and many state officials have made lowering the cost of medicine for patients a top priority. If policymakers are serious about addressing high out-of-pocket costs for patients, they should start by taking steps to finally hold pharmacy benefit managers (PBMs) accountable.

119
119
article thumbnail

UK atrial fibrillation research incorporates Brainomix

Pharma Times

Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients

137
137
article thumbnail

STAT+: Little transparency, lots of waste: NIH funds pediatric research, but many trials results go unpublished

STAT

The National Institutes of Health provided $362 million in grants for clinical trials that enrolled at least 41,000 children over a recent three-year period — but many results were never published, a new analysis found. The results are a worrisome sign of a lack of transparency that can lead to wasted research funding. Specifically, just under two-thirds of the 354 trials studied were registered in advance with ClinicalTrials.gov , the federal database, and just 13% of finished trials wer

265
265
article thumbnail

Woman of the Week: Alltrna’s Michelle Werner

PharmaVoice

The first-time CEO has her sights on addressing thousands of diseases with the company’s tRNA platform.

130
130
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

GenScript ProBio and RVAC partner for Covid-19 vaccine pDNA

Pharmaceutical Technology

GenScript ProBio has announced a strategic collaboration with RVAC Medicines to manufacture GMP-grade plasmid DNA (pDNA) for the latter’s RVM-V001, an mRNA Covid-19 vaccine candidate. Under the agreement, GenScript ProBio will offer GMP plasmid manufacturing service for the RVM-V001 programme. This collaboration is expected to help expedite the clinical manufacturing of RVM-V001 and future mRNA-based vaccines that target infectious diseases such as Clostriodioides difficile infection (CDI) and R

Vaccines 115
article thumbnail

Modus Therapeutics reveals latest sevuparin data

Pharma Times

New top line data has emerged from the company’s phase 1b study evaluating potential for treating sepsis

136
136
article thumbnail

STAT+: FDA’s top tobacco regulator is ready to talk about the benefits of e-cigs versus cigarettes

STAT

WASHINGTON — The head of the FDA’s tobacco center wants to do more to tout the health benefits of switching from cigarettes to e-cigarettes, now that youth vaping rates are declining. “With the reductions in [youth vaping rates] that we’ve seen, we’ve got an opportunity to ramp up our efforts related to the continuum of risk,” said Brian King, director of the FDA’s Center for Tobacco Products, at a Friday event.

265
265